Cardlytics announced second quarter 2026 financial results showing a significant year-over-year contraction, with revenue falling 36% to $36.9 million. The company reported a GAAP Net Loss of $(14.9) million, or $(1.50) per share, and an adjusted EBITDA of $1.7 million, down from $3.0 million in the prior-year period. Management noted that results were within their guidance and highlighted improving margins throughout the quarter.
Key Highlights
- Revenue of $36.9 million represented a 36% decrease year-over-year, missing analyst estimates of $37.52 million.
- Billings, a key performance indicator, came in at $65.5 million, a 34% year-over-year decrease but slightly ahead of the $64.0 million expected by analysts.
- The company reported a GAAP loss of $(1.50) per share from continuing operations, which was better than the expected loss of $(2.30) per share.
- Monthly Qualified Users (MQUs) declined 17% year-over-year to 185.4 million.
- For the third quarter of 2026, Cardlytics guided for revenue between $34.0 million and $39.0 million and Billings between $61.0 million and $67.0 million.